期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 101, 期 2, 页码 170-172出版社
WILEY-BLACKWELL
DOI: 10.1002/cpt.457
关键词
-
资金
- Janssen/JJ
- Wallitt Foundation
- Medical Research Council [MC_U105597119, MC_UU_00005/12] Funding Source: researchfish
- Wellcome Trust [103838/Z/14/Z] Funding Source: researchfish
- MRC [MC_U105597119, MC_UU_00005/12] Funding Source: UKRI
- Wellcome Trust [103838/Z/14/Z] Funding Source: Wellcome Trust
Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Nonpharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of smart and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据